Patiently waiting for clinical validation...
I recently spoke to one of the lead neuroimmunologists in Australia about all things cancer, m6A epitranscriptomics, anthracycline-induced cardiotoxicity, and Zantrenes current status as an FTO inhibitor and cardioprotective agent. He said the value something like that would have is so great that it was difficult to comprehend. He shares my desire for clinical work testing the efficacy of the drug.
Securely held over here.
Patiently waiting for clinical validation...I recently spoke to...
-
- There are more pages in this discussion • 580 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.075(4.53%) |
Mkt cap ! $294.8M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.73 | $1.64 | $271.9K | 161.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 3844 | 2 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |